OICR Cancer Therapeutics Innovation Pipeline
The Ontario Institute for Cancer Research (OICR)’s CTIP program funds preclinical drug discovery projects focused on developing First-in-Class (FiC) or Best-in-Class (BiC) cancer therapeutics. The goal is to build a sustainable pipeline of validated targets and novel molecules that can attract further investment for clinical development. This call supports projects at three stages: Early Validation (EV), Early Accelerator (EA), and Late Accelerator (LA).
Eligibility Criteria:
-
Applicants must be from Ontario academic centres, hospital research institutes, or government research institutions.
-
Funding is only tenable within Ontario.
-
For-profit entities are not eligible to apply.
Funding Details:
-
Early Validation (EV) Projects
-
Goal: Validate cancer-associated targets using knowledge bases and functional assays
-
Amount: Up to 150,000 CAD/year for 2 years
-
-
Early Accelerator (EA) Projects
-
Goal: Develop a validated primary assay and demonstrate screening readiness
-
Amount: Up to 150,000 CAD for 1 year
-
-
Late Accelerator (LA) Projects
-
Goal: Conduct validated screening to identify Hit1 molecules
-
Amount: Up to 500,000 CAD/year for 2 years
-
Deadline:
-
Applications open: April 7, 2025
-
Information session: April 23, 2025 (2:00–3:00 PM ET)
-
Notice of Intent / Letter of Intent: May 13, 2025 (5:00 PM ET)
-
Full Application Deadline: August 7, 2025 (5:00 PM ET)
-
Notification of Decision: October 2025
-
Funding Start Date: December 1, 2025
Where to go for further information:
-
Questions: Email [email protected]
-
Applications via ReportNet
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023